Christine P. Bump, principal and founder of Penn Avenue Law & Policy, is an insightful regulatory attorney with two decades of experience developing and implementing FDA strategies for devices, diagnostics, digital health platforms, and genetic and genomic tests. She advises laboratories, large corporations, and emerging companies with an awareness and understanding of their business and strategic goals. Christine has served as regulatory counsel for a national diagnostic coalition, written several articles, and presented at numerous industry conferences. Before starting her firm, she practiced at Hyman, Phelps, & McNamara, P.C. and in the Life Sciences group at Goodwin. Christine earned a BA from Sweet Briar College, an MPH. from Emory University’s Rollins School of Public Health, and a JD from Emory University School of Law.
Articles by Christine P. Bump
District Court Overturns FDA’s LDT Rule: What the Ruling Means for Clinical Labs Now
Under the district court’s vacatur, the LDT final rule and its compliance deadlines are no longer in effect and cannot be enforced
Webinar Recap: LDT Compliance Requirements for FDA Final Rule
Christine P. Bump shares key insights from the FDA’s August 22 webinar on LDTs compliance
